Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
Globe Newswire•13/10/2026•08:00 ET
0
Key Highlights
- ➤Absci will report Q3 2026 financial and operating results November 12, 2026
- ➤Management will discuss business developments, results, and outlook during an 8:00 a.m. ET webcast
- ➤ABS-201 is being investigated for hair regrowth and potential endometriosis treatment
VANCOUVER, Wash. and NEW YORK, Oct. 13, 2026 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a clinical-stage biopharmaceutical company advancing breakthrough therapeutics designed with generative AI, today announced the company will report business updates and financial and operating results for the third quarter 2026 before market open on Thursday, November 12, 2026.
Absci management will webcast a corresponding conference call beginning at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time) to discuss its business developments, financial and operating results, and outlook.
Get started
Create a free account to read the full story.